Effects of vildagliptin twice daily vs. sitagliptin once daily on reduction of oxidative stress and inflammation by blunting interprandial acute glucose fluctuations in patients with type 2 diabetes - PROBE Design (Multicenter Prospective, Randomized, Open-label parallel group with a blinded-endpoint).
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Vildagliptin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Apr 2012 New trial record